Although most nonmalignant colorectal polyps can be managed endoscopically, a substantial number of patients are still sent for surgery. Complete this program to learn how to differentiate between a simple and complex polyp and help reduce the number of unnecessary surgeries for patients with colorectal polyps.
Three interactive modules will walk you through when to refer a patient for surgical intervention, use case studies to discuss risk factors for an adverse surgical event and highlight the safety and efficacy of using endoscopic resection.
You'll also receive a free interactive decision tool that can be used at any stage of the diagnosis and treatment of colorectal polyps.
Sign in to access
After you sign in, please click the "Launch" button on the top of this page to access the modules.
Learning objectives
- Identify the types of lesions that can be endoscopically resected versus those that need to be surgically resected.
- Explain the benefits of endoscopic resection.
- Differentiate between a simple and complex polyp.
- Discuss the risks associated with open and laparoscopic surgery.
Faculty
Douglas K. Rex, MD, MACG, FASGE, MACP, AGAF (Chair)
Distinguished Professor of Medicine
Indiana University School of Medicine
Chancellor’s Professor
Indiana University Purdue
University of Indianapolis
Director of Endoscopy
Indiana University Hospital
Dennis J. Yang, MD
Associate Professor of Medicine
Advanced Endoscopy Fellowship Program Director
University of Florida College of Medicine
Heiko Pohl, MD
Associate Professor of Medicine
Dartmouth School of Medicine
Director of Endoscopy
Whiter River Junction VA Medical Center
Affiliations:
Sri Komanduri MD, MS FASGE, AGAF
Medical Director, GI Lab
Director of Interventional Endoscopy
Professor of Medicine and Surgery
Division of GI and Hepatology
Feinberg School of Medicine, Northwestern University
V. Raman Muthusamy, MD, MAS, AGAF, FACG, FASGE
Director of Endoscopy, UCLA Health System
Professor of Clinical Medicine
David Geffen School of Medicine at UCLA
Pricing
|
Member
|
Nonmember
|
| $Free |
$Free |
CME / Maintenance of Certification (MOC) Information
Accreditation and Designation Statement
The American Gastroenterological Association (AGA) Institute is accredited by the Accreditation Council
for Continuing Medical Education to provide continuing medical education for physicians.
The AGA Institute designates this enduring material for a maximum of 0.75 AMA PRA Category
1 Credits™. Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all
faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held
within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts
of interest prior to delivering the educational activity to learners.
MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component,
enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM)
Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of
CME credits claimed for the activity. It is the CME activity provider's responsibility to submit
participant completion information to ACCME for the purpose of granting ABIM MOC credit.
MOC/CME expiration date: August 24, 2022
Douglas K. Rex, MD, MACG, FASGE, MACP, AGAF has disclosed that he has received consulting fees from Aries Pharmaceutical, Boston Scientific, Braintree Laboratories, Endokey, GI Supply, Lumendi Ltd, Medtronic, Norgine, and Olympus Corporation; has received grant/research support from EndoAid Ltd, Erbe USA Inc, Olympus Corporation, and Medivators Inc; and has stock ownership in Satisfai Health.
Dennis J. Yang, MD, has disclosed that he has received in-kind support as a consultant from Steris; has received grant/research support from Lumendi, and has stock ownership in Boston Scientific.
Heiko Pohl, MD, has disclosed that he has received grant/research support from Steris and Cosmo Pharmaceuticals and has stock ownership in Satisfai Health.
Sri Komanduri, MD, MS FASGE, AGAF has disclosed that he has received consulting fees from Boston Scientific Corporation and Medtronic.
V. Raman Muthusamy, MD, MAS, AGAF, FACG, FASGE has disclosed that he has received consulting fees from Boston Scientific Corporation, Medtronic, and Medivators; speaking fees from Medtronic and Torax Medical Inc.; and research support from Medtronic.
